TG Therapeutics Inc (TGTX) earnings · P/E 20, rev $616.3M
These earnings events as JSON? API free 100/dayTG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
This TGTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported TGTX revenue for 2025-12-31 was $616.3M. Net income was $447.2M. Revenue was up 87.3% from 2024-12-31 to 2025-12-31. TGTX currently screens at market cap $7.88B and trailing P/E 19.7.
When the next TGTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 87.3% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full TGTX research stays on the stock page; the tape stays on the quote page.
TGTX earnings FAQ
What are TGTX's latest revenue and net income?
Latest cached TG Therapeutics Inc (TGTX) revenue for Dec 31, 2025 was $616.3M. Net income was $447.2M. Statements: https://lician.com/financials/tgtx
What is TGTX's latest diluted EPS?
Latest cached TG Therapeutics Inc (TGTX) diluted EPS for Dec 31, 2025 was $2.77.
What period does the latest TGTX earnings print cover?
The latest cached TG Therapeutics Inc (TGTX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did TGTX revenue change from the prior cached period?
Cached TG Therapeutics Inc (TGTX) revenue was up 87.3% from $329.0M (Dec 31, 2024) to $616.3M (Dec 31, 2025). Statements: https://lician.com/financials/tgtx
What is TGTX's P/E ratio?
TG Therapeutics Inc (TGTX) trailing P/E is 19.7 on the latest cached fundamentals snapshot.
Where are TGTX earnings listed?
Cached earnings facts for TG Therapeutics Inc (TGTX) are listed at https://lician.com/earnings/tgtx. Statements: https://lician.com/financials/tgtx
Not investment advice.